News & AnalysisKoneksa grabs $45m Series CKoneksa, a digital biomarker platform, has secured $45 million in Series C financing.ByIris Dorbian7 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs